Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02253810Completed
Randomised, double-blind trial in hip dysplasia (DDH) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Calculated Total Blood Loss at 1 day. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02253810.